Healthcare Industry - Medical - Pharmaceutical - Biotech

The Drug Safety Summit provides a holistic view of drug safety science, bringing together leaders in Risk Evaluation and Mitigation Strategy, Pharmacovigilance, and Regulatory Affairs to share current best practices and experiences in developing safety/regulatory str ..

Adhere to new clinical data disclosure regulations from the US and EU by understanding all parts of the transparency process and avoiding public misunderstandings and penalties. The CTIS regulations alongside FDA regulations has given the clinical data disclosure ..

This practical course stresses how to enhance your day-to-day office GYN practice with relevant, important procedures and therapies that are easy to master, comfortable to incorporate and solidly reimbursable. Upgrade your skills and clinical approach to meet the nee ..

ICS 2023, 27-29 September in Toronto, will be a great 3-day meeting offering a range of sessions and topics depending upon your speciality and interests. The ICS annual meeting brings together the most renowned international experts in the research and the treatme ..

It has long been understood that the ability to deliver therapeutic cargos to cytosolic sites of action in target tissue could unlock access to previously undruggable targets, whilst enabling the development of safer and efficacious drugs. Now, advances in nanomed ..

The past twelve months have seen an unprecedented level of excitement, investment, and progression within the gene therapy for muscular disorders field. As the industry endeavours to move gene therapy treatment through the preclinical and clinical pipeline, in contex ..

The demand for cell and gene therapies is growing at an exponential rate as an increasing number of drug developers scale up their supply chain operations as their pipelines grow and more candidates are accelerated into the clinic. As numerous therapies progress t ..

Built with biopharmaceutical industry insights, this in-person meeting will bring together KOLs to delve deep into the key remaining challenges when it comes to identifying, designing and developing the next generation of molecular glues and truly unlock the widespre ..

2022 has been a landmark year for the global gene therapy space. With August came the green light for bluebird bio's Zynteglo in the US, the first FDA approval for a gene therapy in over three years. Hot off its heels we saw the accelerated approval of another bluebi ..

With strong effectiveness profiles and 20 years of FDA approval, kinase inhibitors have revolutionized oncology treatment. The success of current kinase inhibitor classes is nevertheless constrained by rising resistance and security concerns. The 2nd Next Generat ..

Expand and Maximize RNA Druggability with Small Molecules As one of the most anticipated events on the RNA calendar, the RNA-Targeted Drug Discovery Summit returns for its fifth year this December. This premier, definitive, and most comprehensive forum for the RNA ..

Welcome to the 2nd mRNA Analytical Development Summit: Trailblazing Advanced Analytics for Superior mRNA Therapeutics and Vaccines Uniting 80+ Senior Scientists, Directors, and Heads of Analytical Development, Quality Control, CMC and Regulatory - join us in Bosto ..

Unlocking the Next Wave of Clinically Relevant GPCR Targets Returning for the 2nd year, the GPCR-Targeted Drug Discovery Summit is the only industry-led meeting of its kind dedicated to congregating the most forward thinking biotechs, established large pharma, and ..

Accelerate the Practical Translation and Clinical Development of Meaningful Therapies for the Treatment of Glioblastoma and Other Life Threatening CNS Tumors Glioblastoma continues to be one of the most devasting diseases, with a severe lack of options available for ..

As cell and gene therapy and genomic medicine pipeline continues to mature, process development for viral vector is becoming critical for drug developers for the next phase, to deliver a quality, transformative cure to patients with affordability. The recent investme ..

A major challenge we face today as primary care clinicians is staying current with the rapid advances in prevention. Prevention is a major component of effective primary care practice and one of the unique strengths that we must possess. Most existing CME courses foc ..

Musculoskeletal Ultrasound (MSKUS) is a cutting-edge procedure being utilized to rapidly diagnose and treat a multitude of musculoskeletal disorders. This comprehensive course will cover the most important practical aspects of MSKUS, including step-by-step instructio ..

With more than 50 interactive lectures and case-based sessions, this CME course provides a comprehensive review in all areas of nephrology. Many practicing nephrologists and physicians find it difficult to keep up with the rapid scientific and technological advanc ..

DNA damage response inhibition has amassed a lot of interest over the last decade as it exposes a massive vulnerability in cancer cells. This has a huge potential to treat many types of tumors such as breast and colorectal cancers, and even notoriously difficult-to-t ..

RNA technologies have taken the world by storm over the pandemic and now the potential to of RNA engineering to enhance cell therapy is finally being realized. The therapeutic potential of RNA cell therapies is huge, but challenges remain in cell-specific delivery ..